Tender detail
Biologics discount agreements 2026 – dornase alfa
Summary
TK is seeking to conclude discount agreements with all suitable pharmaceutical companies for the active ingredient dornase alfa. The agreements use uniform terms, involve no individual negotiations and grant no exclusivity. The term begins on 1 January 2027 and ends no later than 31 December 2028, with a maximum duration of 24 months.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.